Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations

Laura Smith, John Saganty, Patrice Forget

Open source

DOI
10.1007/s11912-024-01572-z
Published
2024-07-06
Container
Current Oncology Reports
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11912-024-01572-z,
  title = {Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations},
  author = {Laura Smith and John Saganty and Patrice Forget},
  year = {2024},
  journal = {Current Oncology Reports},
  doi = {10.1007/s11912-024-01572-z},
  url = {https://doi.org/10.1007/s11912-024-01572-z}
}

RIS

TY  - JOUR
TI  - Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations
AU  - Laura Smith
AU  - John Saganty
AU  - Patrice Forget
PY  - 2024
JO  - Current Oncology Reports
DO  - 10.1007/s11912-024-01572-z
UR  - https://doi.org/10.1007/s11912-024-01572-z
ER  - 

APA

Smith, L., Saganty, J., & Forget, P. (2024). Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations. Current Oncology Reports. https://doi.org/10.1007/s11912-024-01572-z

Source records